Granulomatous disease in common variable immunodeficiency

Clinical Immunology

Volumn 133, Issue 2, 2009, Pages 198-207

  Ardeniz, Ömür ^a   Cunningham Rundles, Charlotte ^b  

^a EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Autoimmunity; Common variable immune deficiency; Granulomatous disease; Lung disease; Mortality; TNF alpha

Indexed keywords

AZATHIOPRINE; CYCLOOXYGENASE 2 INHIBITOR; CYCLOSPORIN; HYDROXYCHLOROQUINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; RITUXIMAB; STEROID;

ADOLESCENT; ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE COURSE; FEMALE; GRANULOMA; GRANULOMATOSIS; HEMOLYTIC ANEMIA; HUMAN; LIVER GRANULOMA; LUNG GRANULOMA; LYMPHADENOPATHY; MALE; MORTALITY; PRIORITY JOURNAL; SPLENECTOMY; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; ANTIBODIES; AUTOIMMUNE DISEASES; B-LYMPHOCYTES; CD4-CD8 RATIO; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; FOLLOW-UP STUDIES; GRANULOMA; HUMANS; LUNG; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; MITOGENS; SPLENECTOMY; T-LYMPHOCYTES; YOUNG ADULT;

EID: 70349762436     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2009.05.001     Document Type: Article

References (67)

1. Cunningham-Rundles C. Common variable immunodeficiency. Curr. Allergy Asthma Rep. 1 (2001) 421-429
2. Geha R.S., Notarangelo L.D., Casanova J.L., Chapel H., Conley M.E., Fischer A., Hammarstrom L., Nonoyama S., Ochs H.D., Puck J.M., Roifman C., Seger R., and Wedgwood J. Primary immunodeficiency diseases: an update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee. J. Allergy Clin. Immunol. 120 (2007) 776-794
3. Chapel H., Lucas M., Lee M., Bjorkander J., Webster D., Grimbacher B., Fieschi C., Thon V., Abedi M.R., and Hammarstrom L. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood 112 (2008) 277-286
4. Conley M.E., Notarangelo L.D., and Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin. Immunol. 93 (1999) 190-197
5. Chapel H., and Cunningham-Rundles C. Update in understanding common variable immunodeficiency disorders (CVIDs) and the management of patients with these conditions. Br. J. Haematol. (2009)
6. Busse P.J., Farzan S., and Cunningham-Rundles C. Pulmonary complications of common variable immunodeficiency. Ann. Allergy Asthma. Immunol. 98 (2007) 1-8 [quiz 8-11, 43]
7. Burton C.M., Milman N., Andersen C.B., Marquart H., and Iversen M. Common variable immune deficiency and lung transplantation. Scand J. Infect. Dis. 39 (2007) 362-367
8. Martinez Garcia M.A., de Rojas M.D., Nauffal Manzur M.D., Munoz Pamplona M.P., Compte Torrero L., Macian V., and Perpina Tordera M. Respiratory disorders in common variable immunodeficiency. Respir. Med. 95 (2001) 191-195
9. Thickett K.M., Kumararatne D.S., Banerjee A.K., Dudley R., and Stableforth D.E. Common variable immune deficiency: respiratory manifestations, pulmonary function and high-resolution CT scan findings. QJM 95 (2002) 655-662
10. Quinti I., Soresina A., Spadaro G., Martino S., Donnanno S., Agostini C., Claudio P., Franco D., Maria Pesce A., Borghese F., Guerra A., Rondelli R., and Plebani A. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J. Clin. Immunol. 27 (2007) 308-316
11. North M.E., Ivory K., Funauchi M., Webster A.D., Lane A.C., and Farrant J. Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin. Exp. Immunol. 105 (1996) 517-522
12. Cunningham-Rundles C., and Bodian C. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin. Immunol. 92 (1999) 34-48
13. Bayry J., Lacroix-Desmazes S., Kazatchkine M.D., Galicier L., Lepelletier Y., Webster D., Levy Y., Eibl M.M., Oksenhendler E., Hermine O., and Kaveri S.V. Common variable immunodeficiency is associated with defective functions of dendritic cells. Blood 104 (2004) 2441-2443
14. Cunningham-Rundles C., and Radigan L. Deficient IL-12 and dendritic cell function in common variable immune deficiency. Clin. Immunol. 115 (2005) 147-153
15. Scott-Taylor T.H., Green M.R., Eren E., and Webster A.D. Monocyte derived dendritic cell responses in common variable immunodeficiency. Clin. Exp. Immunol. 138 (2004) 484-490
16. Grimbacher B., Warnatz K., and Peter H.H. The immunological synapse for B-cell memory: the role of the ICOS and its ligand for the longevity of humoral immunity. Curr. Opin. Allergy Clin. Immunol. 3 (2003) 409-419
17. van Zelm M.C., Reisli I., van der Burg M., Castano D., van Noesel C.J., van Tol M.J., Woellner C., Grimbacher B., Patino P.J., van Dongen J.J., and Franco J.L. An antibody-deficiency syndrome due to mutations in the CD19 gene. N. Engl. J. Med. 354 (2006) 1901-1912
18. Kanegane H., Agematsu K., Futatani T., Sira M.M., Suga K., Sekiguchi T., van Zelm M.C., and Miyawaki T. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun. 8 (2007) 663-670
19. Grimbacher B., Hutloff A., Schlesier M., Glocker E., Warnatz K., Drager R., Eibel H., Fischer B., Schaffer A.A., Mages H.W., Kroczek R.A., and Peter H.H. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat. Immunol. 4 (2003) 261-268
20. Salzer U., Chapel H.M., Webster A.D., Pan-Hammarstrom Q., Schmitt-Graeff A., Schlesier M., Peter H.H., Rockstroh J.K., Schneider P., Schaffer A.A., Hammarstrom L., and Grimbacher B. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat. Genet. 37 (2005) 820-828
21. Castigli E., Wilson S.A., Garibyan L., Rachid R., Bonilla F., Schneider L., and Geha R.S. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat. Genet. 37 (2005) 829-834
22. Pan-Hammarstrom Q., Salzer U., Du L., Bjorkander J., Cunningham-Rundles C., Nelson D.L., Bacchelli C., Gaspar H.B., Offer S., Behrens T.W., Grimbacher B., and Hammarstrom L. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat. Genet. 39 (2007) 429-430
23. Zhang L., Radigan L., Salzer U., Behrens T.W., Grimbacher B., Diaz G., Bussel J., and Cunningham-Rundles C. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes. J. Allergy Clin. Immunol. 120 (2007) 1178-1185
24. Warnatz K., Denz A., Drager R., Braun M., Groth C., Wolff-Vorbeck G., Eibel H., Schlesier M., and Peter H.H. Severe deficiency of switched memory B cells (CD27(+)IgM(-)IgD(-)) in subgroups of patients with common variable immunodeficiency: a new approach to classify a heterogeneous disease. Blood 99 (2002) 1544-1551
25. Piqueras B., Lavenu-Bombled C., Galicier L., Bergeron-van der Cruyssen F., Mouthon L., Chevret S., Debre P., Schmitt C., and Oksenhendler E. Common variable immunodeficiency patient classification based on impaired B cell memory differentiation correlates with clinical aspects. J. Clin. Immunol. 23 (2003) 385-400
26. Wehr C., Kivioja T., Schmitt C., Ferry B., Witte T., Eren E., Vlkova M., Hernandez M., Detkova D., Bos P.R., Poerksen G., von Bernuth H., Baumann U., Goldacker S., Gutenberger S., Schlesier M., Bergeron-van der Cruyssen F., Le Garff M., Debre P., Jacobs R., Jones J., Bateman E., Litzman J., van Hagen P.M., Plebani A., Schmidt R.E., Thon V., Quinti I., Espanol T., Webster A.D., Chapel H., Vihinen M., Oksenhendler E., Peter H.H., and Warnatz K. The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood 111 (2008) 77-85
27. Sanchez-Ramon S., Radigan L., Yu J.E., Bard S., and Cunningham-Rundles C. Memory B cells in common variable immunodeficiency: clinical associations and sex differences. Clin. Immunol. 128 (2008) 314-321
28. Ko J., Radigan L., and Cunningham-Rundles C. Immune competence and switched memory B cells in common variable immunodeficiency. Clin. Immunol. 116 (2005) 37-41
29. Arnold D.F., Wiggins J., Cunningham-Rundles C., Misbah S.A., and Chapel H.M. Granulomatous disease: distinguishing primary antibody disease from sarcoidosis. Clin. Immunol. 128 (2008) 18-22
30. Fasano M.B., Sullivan K.E., Sarpong S.B., Wood R.A., Jones S.M., Johns C.J., Lederman H.M., Bykowsky M.J., Greene J.M., and Winkelstein J.A. Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature. Medicine (Baltimore) 75 (1996) 251-261
31. Mechanic L.J., Dikman S., and Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Ann. Intern. Med. 127 (1997) 613-617
32. Kanathur N., Byrd Jr. R.P., Fields C.L., and Roy T.M. Noncaseating granulomatous disease in common variable immunodeficiency. South Med. J. 93 (2000) 631-633
33. Morimoto Y., and Routes J.M. Granulomatous disease in common variable immunodeficiency. Curr. Allergy Asthma. Rep. 5 (2005) 370-375
34. Bates C.A., Ellison M.C., Lynch D.A., Cool C.D., Brown K.K., and Routes J.M. Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency. J. Allergy Clin. Immunol. 114 (2004) 415-421
35. Mullighan C.G., Fanning G.C., Chapel H.M., and Welsh K.I. TNF and lymphotoxin-alpha polymorphisms associated with common variable immunodeficiency: role in the pathogenesis of granulomatous disease. J. Immunol. 159 (1997) 6236-6241
36. Cunningham-Rundles C. Hematologic complications of primary immune deficiencies. Blood Rev. 16 (2002) 61-64
37. Cunningham-Rundles C. Autoimmune manifestations in common variable immunodeficiency. J. Clin. Immunol. 28 Suppl. 1 (2008) S42-S45
38. Pujol R.M., Nadal C., Taberner R., Diaz C., Miralles J., and Alomar A. Cutaneous granulomatous lesions in common variable immunodeficiency: complete resolution after intravenous immunoglobulins. Dermatology 198 (1999) 156-158
39. Krupnick A.I., Shim H., Phelps R.G., Cunningham-Rundles C., and Sapadin A.N. Cutaneous granulomas masquerading as tuberculoid leprosy in a patient with congenital combined immunodeficiency. Mt. Sinai. J. Med. 68 (2001) 326-330
40. Meyer A., Lachmann H.J., Webster A.D., Burns A., and Thway K. Hypercalcemia in a patient with common variable immunodeficiency and renal granulomas. Am. J. Kidney Dis. 45 (2005) e90-e93
41. Lin J.H., Liebhaber M., Roberts R.L., Dyer Z., and Stiehm E.R. Etanercept treatment of cutaneous granulomas in common variable immunodeficiency. J. Allergy Clin. Immunol. 117 (2006) 878-882
42. Misbah S.A., Spickett G.P., Esiri M.M., Hughes J.T., Matthews W.B., Thompson R.A., and Chapel H.M. Recurrent intra-cranial granulomata presenting as space-occupying lesions in a patient with common variable immunodeficiency. Postgrad. Med. J. 68 (1992) 359-362
43. North M.E., Webster A.D., and Farrant J. Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-gamma) in CD28+ ('cytotoxic') and CD28- ('suppressor') CD8+ subsets. Clin. Exp. Immunol. 111 (1998) 70-75
44. Hatab A.Z., and Ballas Z.K. Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J. Allergy Clin. Immunol. 116 (2005) 1161-1162
45. Mrusek S., Marx A., Kummerle-Deschner J., Tzaribachev N., Enders A., Riede U.N., Warnatz K., Dannecker G.E., and Ehl S. Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii. Clin. Exp. Immunol. 137 (2004) 578-583
46. Wheat W.H., Cool C.D., Morimoto Y., Rai P.R., Kirkpatrick C.H., Lindenbaum B.A., Bates C.A., Ellison M.C., Serls A.E., Brown K.K., and Routes J.M. Possible role of human herpesvirus 8 in the lymphoproliferative disorders in common variable immunodeficiency. J. Exp. Med. 202 (2005) 479-484
47. Iannuzzi M.C., Rybicki B.A., and Teirstein A.S. Sarcoidosis. N. Engl. J. Med. 357 (2007) 2153-2165
48. Grunewald J., and Eklund A. Role of CD4+ T cells in sarcoidosis. Proc. Am. Thorac. Soc. 4 (2007) 461-464
49. Fehrenbach H., Zissel G., Goldmann T., Tschernig T., Vollmer E., Pabst R., and Muller-Quernheim J. Alveolar macrophages are the main source for tumour necrosis factor-alpha in patients with sarcoidosis. Eur. Respir. J. 21 (2003) 421-428
50. Barnes P.F., Fong S.J., Brennan P.J., Twomey P.E., Mazumder A., and Modlin R.L. Local production of tumor necrosis factor and IFN-gamma in tuberculous pleuritis. J. Immunol. 145 (1990) 149-154
51. Aly S., Laskay T., Mages J., Malzan A., Lang R., and Ehlers S. Interferon-gamma-dependent mechanisms of mycobacteria-induced pulmonary immunopathology: the role of angiostasis and CXCR3-targeted chemokines for granuloma necrosis. J. Pathol. 212 (2007) 295-305
52. Roach D.R., Bean A.G., Demangel C., France M.P., Briscoe H., and Britton W.J. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J. Immunol. 168 (2002) 4620-4627
53. Saunders B.M., Tran S., Ruuls S., Sedgwick J.D., Briscoe H., and Britton W.J. Transmembrane TNF is sufficient to initiate cell migration and granuloma formation and provide acute, but not long-term, control of Mycobacterium tuberculosis infection. J. Immunol. 174 (2005) 4852-4859
54. Giovannetti A., Pierdominici M., Mazzetta F., Marziali M., Renzi C., Mileo A.M., De Felice M., Mora B., Esposito A., Carello R., Pizzuti A., Paggi M.G., Paganelli R., Malorni W., and Aiuti F. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J. Immunol. 178 (2007) 3932-3943
55. Cambronero R., Sewell W.A., North M.E., Webster A.D., and Farrant J. Up-regulation of IL-12 in monocytes: a fundamental defect in common variable immunodeficiency. J. Immunol. 164 (2000) 488-494
56. Aukrust P., Lien E., Kristoffersen A.K., Muller F., Haug C.J., Espevik T., and Froland S.S. Persistent activation of the tumor necrosis factor system in a subgroup of patients with common variable immunodeficiency-possible immunologic and clinical consequences. Blood 87 (1996) 674-681
57. Cunningham-Rundles C., Radigan L., Knight A.K., Zhang L., Bauer L., and Nakazawa A. TLR9 activation is defective in common variable immune deficiency. J. Immunol. 176 (2006) 1978-1987
58. Ito T., Schaller M., Hogaboam C.M., Standiford T.J., Chensue S.W., and Kunkel S.L. TLR9 activation is a key event for the maintenance of a mycobacterial antigen-elicited pulmonary granulomatous response. Eur. J. Immunol. 37 (2007) 2847-2855
59. Kalia S., and Dutz J.P. New concepts in antimalarial use and mode of action in dermatology. Dermatol. Ther. 20 (2007) 160-174
60. Davies C.W., Juniper M.C., Gray W., Gleeson F.V., Chapel H.M., and Davies R.J. Lymphoid interstitial pneumonitis associated with common variable hypogammaglobulinaemia treated with cyclosporin A. Thorax 55 (2000) 88-90
61. Kahler C.M., Heininger P., Loeffler-Ragg J., and Vogelsinger H. Infliximab therapy in pulmonary sarcoidosis. Am. J. Respir. Crit. Care. Med. 176 (2007) 417 [author reply 417-8]
62. Wells A.U. Infliximab in extrapulmonary sarcoidosis: tantalising but inconclusive. Eur. Respir. J. 31 (2008) 1148-1149
63. Smith K.J., and Skelton H. Common variable immunodeficiency treated with a recombinant human IgG, tumour necrosis factor-alpha receptor fusion protein. Br. J. Dermatol. 144 (2001) 597-600
64. Thatayatikom A., Thatayatikom S., and White A.J. Infliximab treatment for severe granulomatous disease in common variable immunodeficiency: a case report and review of the literature. Ann. Allergy Asthma Immunol. 95 (2005) 293-300
65. Zwerner J., and Fiorentino D. Mycophenolate mofetil. Dermatol. Ther. 20 (2007) 229-238
66. Le Guern V., Le Roux G., Martin A., Feuillard J., Cohen P., Poirel H., Raphael M., Guillevin L., and Mouthon L. Lymphoma complicating common variable immunodeficiency with granulomatous disease: report of two cases. Eur. J. Haematol. 71 (2003) 459-463
67. Sharma O.P. Hypercalcemia in granulomatous disorders: a clinical review. Curr. Opin. Pulm. Med. 6 (2000) 442-447